Conference
ANNEXA (TM)-R Part 2: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial Demonstrating Sustained Reversal of Rivaroxaban-Induced Anticoagulation in Older Subjects by Andexanet Alfa (PRT064445), a Universal Antidote for Factor XA (FXA) Inhibitors
Authors
Crowther M; Gold A; Lu G; Leeds JM; Wiens BL; Marthur V; Castillo J; Conley PB; Connolly SJ; Curnutte JT
Volume
132
Pagination
pp. 2274-2274
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
December 8, 2015
Name of conference
Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium
Conference place
Chicago, IL
Conference start date
November 15, 2015
Conference end date
November 19, 2015
Conference proceedings
CIRCULATION
Issue
23
ISSN
0009-7322